Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunochemotherapy”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Testing effectiveness (Phase 2)Study completedNCT02285413
What this trial is testing

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Who this might be right for
Melanoma
Radboud University Medical Center 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07812493
What this trial is testing

Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

Who this might be right for
PirtobrutinibImmunochemotherapyDLBCL - Diffuse Large B Cell Lymphoma+1 more
Pengpeng Xu 24
Testing effectiveness (Phase 2)WithdrawnNCT00829205
What this trial is testing

Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
Cancer Research UK
Large-scale testing (Phase 3)Study completedNCT00257530
What this trial is testing

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Drugs for Neglected Diseases 80
Early research (Phase 1)Study completedNCT00003543
What this trial is testing

Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT00594815
What this trial is testing

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 52
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Very early researchStudy completedNCT02405078
What this trial is testing

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07072351
What this trial is testing

Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaHypofractionated RadiotherapyImmunotherapy+1 more
West China Hospital 88
Testing effectiveness (Phase 2)Looking for participantsNCT05170503
What this trial is testing

Neoadjuvant Immunochemotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma

Who this might be right for
Esophagogastric Junction Adenocarcinoma
Sun Yat-sen University 37
Not applicableNot Yet RecruitingNCT07778056
What this trial is testing

Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation Study

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Henan Cancer Hospital 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011823
What this trial is testing

Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC

Who this might be right for
Triple-Negative Breast Neoplasm
Gangnam Severance Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05290090
What this trial is testing

ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Zhejiang Cancer Hospital 31
Testing effectiveness (Phase 2)Looking for participantsNCT05992597
What this trial is testing

ZR2 Sequential Immunochemotherapy for Newly Treated MCL

Who this might be right for
Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
Zhejiang Cancer Hospital 48
Post-approval studies (Phase 4)Not Yet RecruitingNCT06963593
What this trial is testing

Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy

Who this might be right for
Advanced Gastroesophageal Cancer
Peking University 220
Testing effectiveness (Phase 2)UnknownNCT05964101
What this trial is testing

Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma

Who this might be right for
NeoplasmsCarcinoma, SquamousAntineoplastic Agents
The First Affiliated Hospital of Guangzhou Medical University 25
Post-approval studies (Phase 4)UnknownNCT01768195
What this trial is testing

Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy

Who this might be right for
Hepatitis B
Peking University 80
Testing effectiveness (Phase 2)Looking for participantsNCT07086469
What this trial is testing

Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ToripalimabSurufatinibNeoadjuvant Immunochemotherapy+2 more
Sun Yat-sen University 69
Post-approval studies (Phase 4)Active Not RecruitingNCT05689671
What this trial is testing

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma

Who this might be right for
Non-Small Cell Lung Cancer Metastatic
Nikolaj Frost MD 136
Testing effectiveness (Phase 2)Study completedNCT01458730
What this trial is testing

Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Who this might be right for
Central Nervous System Lymphoma
University of Aarhus 66
Next Page